U.S. researchers say they found that patients taking statins for at least six months dropped their risk of lung cancer by 55%, with nearly all the patients being male. Researchers say protection by cholesterol-lowering statins appears to grow the longer they are taken, with those patients taking statins four years or more having a 77% reduction in lung cancer risk.

Full Story:

Related Summaries